Related references
Note: Only part of the references are listed.Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
Ning Tang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Clinical Characteristics of Coronavirus Disease 2019 in China
W. Guan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses
Furong Qi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Alexandra C. Walls et al.
CELL (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Race to find COVID-19 treatments accelerates
Kai Kupferschmidt et al.
SCIENCE (2020)
In Vitro and Animal Models for SARS-CoV-2 research
Kazuo Takayama
TRENDS IN PHARMACOLOGICAL SCIENCES (2020)
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
Xiuyuan Ou et al.
NATURE COMMUNICATIONS (2020)
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
Ning Tang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
Chaomin Wu et al.
JAMA INTERNAL MEDICINE (2020)
Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?
Andrew I. Ritchie et al.
LANCET (2020)
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta et al.
LANCET (2020)
Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19
Xiaoyan Liu et al.
ACTA PHARMACEUTICA SINICA B (2020)
Fair Allocation of Scarce Medical Resources in the Time of Covid-19
Ezekiel J. Emanuel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Molecular immune pathogenesis and diagnosis of COVID-19
Xiaowei Li et al.
JOURNAL OF PHARMACEUTICAL ANALYSIS (2020)
Coagulation abnormalities and thrombosis in patients with COVID-19
Marcel Levi et al.
LANCET HAEMATOLOGY (2020)
The MERS-CoV Receptor DPP4 as a Candidate Binding Target of the SARS-CoV-2 Spike
Yu Li et al.
ISCIENCE (2020)
Is there a role for tissue plasminogen activator as a novel treatment for refractory COVID-19 associated acute respiratory distress syndrome?
Hunter B. Moore et al.
JOURNAL OF TRAUMA AND ACUTE CARE SURGERY (2020)
In Silico Evaluation of the Effectivity of Approved Protease Inhibitors against the Main Protease of the Novel SARS-CoV-2 Virus
Phaedra Eleftheriou et al.
MOLECULES (2020)
Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study
Sebastiano Bruno Solerte et al.
DIABETES CARE (2020)
Impact of Comorbidities and Glycemia at Admission and Dipeptidyl Peptidase 4 Inhibitors in Patients With Type 2 Diabetes With COVID-19: A Case Series From an Academic Hospital in Lombardy, Italy
Marco Mirani et al.
DIABETES CARE (2020)
Reduced COVID-19 Mortality With Sitagliptin Treatment? Weighing the Dissemination of Potentially Lifesaving Findings Against the Assurance of High Scientific Standards
Michael A. Nauck et al.
DIABETES CARE (2020)
Cell and animal models of SARS-CoV-2 pathogenesis and immunity
Sarah R. Leist et al.
DISEASE MODELS & MECHANISMS (2020)
Targeting adenosinergic pathway and adenosine A2A receptor signaling for the treatment of COVID-19: A hypothesis
Mohamed A. Abouelkhair
MEDICAL HYPOTHESES (2020)
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status
Yan-Rong Guo et al.
MILITARY MEDICAL RESEARCH (2020)
Emerging COVID-19 coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26
Naveen Vankadari et al.
EMERGING MICROBES & INFECTIONS (2020)
A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses
Sin-Yee Fung et al.
EMERGING MICROBES & INFECTIONS (2020)
Adenosine deaminase-1 delineates human follicular helper T cell function and is altered with HIV
Virginie Tardif et al.
NATURE COMMUNICATIONS (2019)
Therapeutic potential of adenosine kinase inhibition-Revisited
Michael F. Jarvis
PHARMACOLOGY RESEARCH & PERSPECTIVES (2019)
Adenosine signaling and adenosine deaminase regulation of immune responses: impact on the immunopathogenesis of HIV infection
Daniela F. Passos et al.
PURINERGIC SIGNALLING (2018)
Adaptive Evolution of MERS-CoV to Species Variation in DPP4
Michael Letko et al.
CELL REPORTS (2018)
DPP4, the Middle East Respiratory Syndrome Coronavirus Receptor, is Upregulated in Lungs of Smokers and Chronic Obstructive Pulmonary Disease Patients
Leen J. M. Seys et al.
CLINICAL INFECTIOUS DISEASES (2018)
Tissue Distribution of the MERS-Coronavirus Receptor in Bats
W. Widagdo et al.
SCIENTIFIC REPORTS (2017)
Inhibition of Adenosine Kinase Attenuates Acute Lung Injury
David Koehler et al.
CRITICAL CARE MEDICINE (2016)
South (S)- and North (N)-Methanocarba-7-Deazaadenosine Analogues as Inhibitors of Human Adenosine Kinase
Kiran S. Toti et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Adenosine Deaminase Inhibitor EHNA Exhibits a Potent Anticancer Effect Against Malignant Pleural Mesothelioma
Yasuhiro Nakajima et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
Impact of Late Oseltamivir Treatment on Influenza Symptoms in the Outpatient Setting: Results of a Randomized Trial
Huong Q. McLean et al.
OPEN FORUM INFECTIOUS DISEASES (2015)
Diabetes Metabolism: Research and Reviews - Chinese Diabetes Society special issue: a small but encouraging step toward the successful control of diabetes in China INTRODUCTION
Jianping Weng et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2014)
Adenosine Deaminase Acts as a Natural Antagonist for Dipeptidyl Peptidase 4-Mediated Entry of the Middle East Respiratory Syndrome Coronavirus
V. Stalin Raj et al.
JOURNAL OF VIROLOGY (2014)
Host Species Restriction of Middle East Respiratory Syndrome Coronavirus through Its Receptor, Dipeptidyl Peptidase 4
Neeltje van Doremalen et al.
JOURNAL OF VIROLOGY (2014)
Receptor Variation and Susceptibility to Middle East Respiratory Syndrome Coronavirus Infection
Arlene Barlan et al.
JOURNAL OF VIROLOGY (2014)
Identification of residues on human receptor DPP4 critical for MERS-CoV binding and entry
Wenfei Song et al.
VIROLOGY (2014)
Repression of the Equilibrative Nucleoside Transporters Dampens Inflammatory Lung Injury
Julio C. Morote-Garcia et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2013)
The catalytic site structural gate of adenosine deaminase allosterically modulates ligand binding to adenosine receptors
Eduard Gracia et al.
FASEB JOURNAL (2013)
Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26
Guangwen Lu et al.
NATURE (2013)
Unveiling the binding mode of adenosine deaminase inhibitors to the active site of the enzyme: implication for rational drug design
Maria Letizia Trincavelli
PURINERGIC SIGNALLING (2013)
Adenosine Kinase: Exploitation for Therapeutic Gain
Detlev Boison
PHARMACOLOGICAL REVIEWS (2013)
Anti-platelet therapy: phosphodiesterase inhibitors
Paolo Gresele et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Adenosine and blood platelets
Hillary A. Johnston-Cox et al.
PURINERGIC SIGNALLING (2011)
Hypoxia-inducible Factor-Dependent Repression of Equilibrative Nucleoside Transporter 2 Attenuates Mucosal Inflammation During Intestinal Hypoxia
Julio C. Morote-Garcia et al.
GASTROENTEROLOGY (2009)
CD39/ectonucleoside triphosphate diphosphohydrolase 1 provides myocardial protection during cardiac ischemia/reperfusion injury
David Koehler et al.
CIRCULATION (2007)
Anticonvulsant and antinociceptive actions of novel adenosine kinase inhibitors
S McGaraughty et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2005)
Crystal structure of human dipeptidyl peptidase IV/CD26 in complex with a substrate analog
HB Rasmussen et al.
NATURE STRUCTURAL BIOLOGY (2003)
Neonatal hepatic steatosis by disruption of the adenosine kinase gene
D Boison et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
CD26: A multifunctional integral membrane and secreted protein of activated lymphocytes
MD Gorrell et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2001)
Share Paper
